This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
The information provider reported on May 1 first-quarter operating profit of $386 million, or 38 cents a share, compared to year-earlier earnings of $396 million, or 30 cents..
"We are upgrading shares of TRI from Underperform to Buy," Bank of America Merrill Lynch analysts wrote in a May 3 report. "We may be early on TRI shares, but there were clear signs of improvement in 1Q12 results. The declines in net sales in Financial & Risk (57% of revenue) improved versus 4Q. Legal (24% of revenue) saw organic revenue accelerate versus 4Q. Even in the tough current environment, we still expect slight YoY adjusted EPS growth in 2012. We also argue that TRI's 4% dividend yield helps support the stock. We expect TRI to use proceeds from the pending $1.25bn sale of its Healthcare unit to make tactical acquisitions and modest share repurchases."
Forward Annual Dividend Yield: 4.3%